Board of Directors
Dr. Frank Wang
Dr. Frank Wang is currently President, CEO and Founder of BioMedomics, Inc., located at Research Triangle Park, North Carolina. BioMedomics is a biotech company focusing on drug discovery & development, and medical diagnostics. At BioMedomics, Dr. Wang is directly involved in fund raising, corporation operation, marketing and sales.
From 2001 to 2006, Dr. Wang was the President and Co-founder of BioMachines, Inc. BioMachines is an enabling technology company applying proprietary advanced technologies in the biomedical and biopharmaceutical marketplace. Prior to starting Biomachines, Dr. Wang founded US Subsidiary of JUKI, a Japanese semiconductor equipment manufacturing company and served as General Manger of JUKI Corporation’s US operations at RTP, NC (1998-2001). He created operation Infrastructure and established international business communication between Japan and US. Prior to JUKI, Dr. Wang worked at a Swiss company Zevatech (1996-1998), RTP, NC, as Senior Manger to manage product development for automated semiconductor manufacture process. Before his industry experience, Dr. Wang worked as an Assistant Professor at University of North Carolina at Chapel Hill (1993-1996) where he published a book and scientific papers on Biophysics and Bioengineering research areas. Dr. Wang received awards from Witaker Foundation, American Heart Association, and Sanofi Winthrop. He also has patents in Bioengineering and semiconductor process fields. Dr. Wang had Technology MBA training and obtained his Ph.D. in Applied Physics from Osaka University, Japan and B.S in EE from Southeast University, Nanjing, China. Dr. Wang actively involved with community service. Dr. Wang was also a speaker and lecturer for Duke Fuqua Business school about global business development related to China.
Mr. Peter Cheng
Mr. Peter Cheng is President of CC Regional Center, a real estate investment company of stellar reputation that is well known in Raleigh/Durham area with leading EB-5 program. With large base of credible investors, he is sought after by many as the go to person for collaboration and assurance of successful real estate projects funding in both residential and commercial.
Mr. Peter Cheng is also President of BMP. BMP has delivered tremendous bottom line impact to supply chain of small, medium and large size North American companies by providing turnkey cost saving solutions. With its strong ties in China, BMP promotes U.S. made products in China and has helped a number of U.S. companies break into China market, a few of which became well known name in its industries in China. With investors from both the U.S. and China, BMP has the capability to incubate companies for both U.S. and China clients and is active in M&A of manufacturing industry.
He is a Triangle Business Journal 40 Under 40 Leadership Award winner and Business Leader’s Triangle Top Catalyst Entrepreneurs winner. Besides his business life, Peter is active with community work. He is Board of Director of North Carolina Chinese Business Association, and was Board of Director of Chinese Association for Science and Technology NC Chapter. He served as Vice President of Chinese American Friendship Association. He was awarded Community Outstanding and Dedicated Service for many years. He is former Head of Computer Posse at Raleigh Rescue Mission. He speaks at job seminars in Duke University, University of North Carolina and North Carolina State University. He has coached many international students and professionals with their career development.
Ms. YanChing Zhang
Dr Zhang is a PhD physicist / engineer with an extensive background in sales and general management. My passion is with helping my clients to be the most successful in their field, driving a business through collaboration, and am extremely energized with making people around me the best they can be.
Ms. Jing Wang
Astute leader with expertise across operations management, procurement & supply chain optimization, and financial management.Accomplished and dedicated manager equipped with strong business acumen, financial acuity, and deep knowledge of new product delivery activities management and global supply chain operations. Lead procurement team focusing on new products sourcing decisions with in-depth product cost management knowledge. Analyze and interpret financial records to isolate trends, identify areas for improvement, and assess overall performance.
Dr. Linxian Wu
Dr. Linxian Wu was born and raised in ChangTing City, Fujian Province, China, and graduated from Xiamen University with a B.Sc. in Microbiology. Dr. Wu has worked in national pharmaceutical and biological product agencies in Beijing, China and Ottawa, Canada, and holds a Ph.D. in Medical Microbiology and Infectious Diseases from the University of Alberta, Canada. Dr. Wu performed his post-doctoral fellow training in Molecular Virology and Immunology at the Medical College of Pennsylvania, where he also remained as a faculty member. Dr. Wu’s scientific credentials include seven USA patents, two EU patents and one World patent, and numerous peer reviewed articles.
Dr. Wu has been further trained in executive programs at Wharton Business School, Stanford University Business School, and INSEAD in Paris, France. He has extensive senior corporate management experience with companies public and private, and with a US subsidiary of a German conglomerate multi-national corporation. His tenure includes the areas of clinical diagnostics, medical devices, biopharmaceuticals and pharmaceuticals. He was the Executive Vice President and Chief Technology Officer of Gull Laboratories, Inc., Salt Lake City, UT, President and Chief Operating Officer of Fresenius Hemocare Inc., Seattle, WA, and President and Chief Operating Officer of Fresenius Kabi Clayton LP, Clayton, NC. He has been an adjunct business professor at the Martha and Spencer Love Business School of Elon University and has taught International Business to MBA students.
Dr. Wu was also the Dean of the BioNetwork Capstone Center of the NC Community College System, had established and managed a consortium program supported by the state of North Carolina to enhance the educational level of North Carolinians in the areas of biopharmaceutical and pharmaceutical operations. In March 2011, Dr. Wu returned to industry and had held the positions of Director of Client Interfacing & Business Development, Director of Biotech and Pharmaceutical Services, and Laboratory Director of Forensic Science at RJ Lee Group Inc., a leading trace materials characterization laboratory and industrial forensics consulting firm (www.rjleegroup.com). After his retirement in May 2015, Dr. Wu has been continuously active professionally and has been selectively taking independent executive consultation projects, including but not limited to advisory capacities for career development and advancement, and the COO functions for BioMedomics, Inc.